Once it was not released in market I suspected it would not be good. And it was not.
The problem with this 4c is it cites the covid pandemic as the reason for sales problems but Phillips has been telling us since this began that the 1A was gong to benefit and it would drive sales. This has not happened. It may have impacted the sale of the newer products but we were told the 1A was going to benefit, especially in China.
The positive is its a very tightly held stock, really does trade around the margins so it should hold up OK as those who own tend to be true believers.
The science has never really been the issue, they just cannot sell.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.506M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90000 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 36903 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable